Regeneron sees rejection one day, US FDA approval the next
The US FDA has approved Regeneron’s latest indication for eye drug Eylea, just four days after rejecting the sBLA in a complete response letter.
Archives for August 17, 2018
Samsung looks to expand CDMO biz with $22bn investment
Samsung plans to invest KRW 180 trillion into its various businesses over the next three years, including in biomanufacturing-focused Samsung BioLogics.
Japanese scientists conduct first clinical trial for Parkinson’s using iPS cells
Japanese scientists at Kyoto University were granted government permission to begin clinical trials using reprogrammed adult stem cells.